BGV
Investor profile
Venture capital
BGV has backed 5 European tech companies across 5 funding rounds between 2021 and 2026, joining rounds totalling €230M. Most active in Software and Cloud. Data as of Nov 2026.
Deals
5
distinct rounds
Companies
5
backed
Active span
2021–2026
6 yrs
Total round €
€230M
sum of rounds joined
Deals by year
distinct rounds / yearBGV — deals by year — interactive chart.
Data table
| BGV — deals by year | |
|---|---|
| 2021 | 2 |
| 2022 | 1 |
| 2026 | 2 |
Top sectors
by dealsBGV — top sectors — interactive chart.
Data table
| BGV — top sectors | |
|---|---|
| Software | 2 |
| Cloud | 1 |
| Healthtech | 1 |
| Cybersecurity | 1 |
Stages
by dealsBGV — stages — interactive chart.
Data table
| BGV — stages | |
|---|---|
| Other | 2 |
| Seed | 1 |
| Series A | 1 |
| Series D+ | 1 |
Countries
by dealsBGV — countries — interactive chart.
Data table
| BGV — countries | |
|---|---|
| France | 4 |
| Netherlands | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Partech Ventures2
- Adara Ventures1
- Amadeus Capital Partners1
- Anamcara Capital1
- Bpifrance1
- BY Venture Partners1
- CentraleSupélec Venture1
- Digital Plus Partners1
- Elaia Partners1
- Eurazeo1
- FJ Labs1
- Forbion1
- Forbion Growth1
- Hi Inov1
- Interlace Ventures1
- Iris Capital1
- Morgan Stanley Expansion Capital1
- New Science Ventures1
- Novo Seeds1
- Revaia1
- Serena Capital1
- Sofinnova Partners1
- True Ventures1
- venBio Partners1
- Ysios Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Platform.sh | France | 1 | €133M |
| Northsea Therapeutics | Netherlands | 1 | €71M |
| OpsMill | France | 1 | €12M |
| Goodweek | France | 1 | €11M |
| Cryptosense | France | 1 | €4.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Platform.sh | Series D+ | €133M | 2022-06 |
| Northsea Therapeutics | Other | €71M | 2021-12 |
| OpsMill | Series A | €12M | 2026-05 |
| Cryptosense | Other | €4.0M | 2021-05 |